Serum carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9) levels were significantly higher in the IPMN/IPMC group than in the IOPN-P group. The gene discussed is CEACAM5; the disease is pancreatic intraductal papillary-mucinous neoplasm.